RaySearch Laboratories AB (publ) (STO:RAY.B)
Sweden · Delayed Price · Currency is SEK 217.20
-6.20 (-2.78%)
Apr 24, 2026, 5:29 PM CET
RaySearch Laboratories AB Market Cap
RaySearch Laboratories AB has a market cap or net worth of 7.66 billion as of April 24, 2026. Its market cap has decreased by -5.55% in one year.
Market Cap
7.66B
Enterprise Value
7.65B
Revenue
1.34B
Ranking
n/a
PE Ratio
33.62
Stock Price
217.20
Market Cap Chart
Since October 30, 2003, RaySearch Laboratories AB's market cap has increased from 189.23M to 7.66B, an increase of 3,947.27%. That is a compound annual growth rate of 17.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 7.66B | -2.02% |
| Dec 30, 2025 | 7.82B | 5.56% |
| Dec 30, 2024 | 7.41B | 139.20% |
| Dec 29, 2023 | 3.10B | 32.79% |
| Dec 30, 2022 | 2.33B | 20.35% |
| Dec 30, 2021 | 1.94B | -31.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 140.41B |
| Getinge AB | 53.38B |
| Sectra AB | 52.14B |
| Camurus AB | 33.97B |
| Ambea AB | 11.26B |
| Dynavox Group AB | 9.97B |
| Xvivo Perfusion AB | 9.31B |
| Synsam AB | 8.79B |